• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Star Equity Holdings Inc. (Amendment)

    6/22/22 5:07:07 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $STRR alert in real time by email
    SC 13D/A 1 sc13da309271004_06222022.htm

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    SCHEDULE 13D

    (Rule 13d-101)

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

    § 240.13d-2(a)

    (Amendment No. 3)1

    Star Equity Holdings, Inc.

    (Name of Issuer)

    Common Stock, par value $0.0001 per share

    (Title of Class of Securities)

    85513Q103

    (CUSIP Number)

     

    JEFFREY E. EBERWEIN

    53 Forest Avenue, Suite 101

    Old Greenwich, Connecticut 06870

    (203) 489-9500

    (Name, Address and Telephone Number of Person

    Authorized to Receive Notices and Communications)

     

    June 17, 2022

    (Date of Event Which Requires Filing of This Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨.

    Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See § 240.13d-7 for other parties to whom copies are to be sent.

     

     

     

    1              The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    CUSIP No. 85513Q103

      1   NAME OF REPORTING PERSON  
             
            JEFFREY E. EBERWEIN  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            PF, OO  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            USA  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         3,550,054*  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         -0-  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              3,550,054*  
        10   SHARED DISPOSITIVE POWER  
               
              -0-  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            3,550,054*  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            21.97%  
      14   TYPE OF REPORTING PERSON  
             
            IN  

      

    * Includes 1,075,000 Shares underlying the Warrants (as defined herein) that are immediately exercisable.

    2

    CUSIP No. 85513Q103

    The following constitutes Amendment No. 3 to the Schedule 13D filed by the undersigned (the “Amendment No. 3”). This Amendment No. 3 amends the Schedule 13D as specifically set forth herein.

    Item 3.Source and Amount of Funds or Other Consideration.

    Capitalized terms not defined herein shall have the meanings set forth in the original Schedule 13D. Item 3 is hereby amended and restated to read as follows:

    Of the 3,550,054 Shares deemed beneficially owned by Mr. Eberwein, (i) 1,075,000 Shares and 1,075,000 accompanying warrants for an additional 1,075,000 Shares (the “Warrants”) were acquired directly from the underwriter in an underwritten public offering conducted by the Issuer that closed on January 24, 2022 (the “2022 Public Offering”), (ii) 650,000 Shares were acquired pursuant to that certain Purchase Agreement, (iii) 625,325 Shares were acquired via a combination of purchases with personal funds in the open market (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business), (iv) 72,459 Shares were acquired upon the vesting of certain Restricted Stock Units awarded to Mr. Eberwein in connection with his service as the Executive Chairman of the Issuer’s Board, (v) 44,000 Shares were acquired in a public offering consummated in May 2020 (the “2020 Public Offering”), and (vi) 8,270 Shares are restricted stock units vesting within 60 days of June 22, 2022.

    The aggregate purchase price of the Shares purchased in the open market and in the 2022 Public Offering and 2020 Public Offering is approximately $5,045,012, excluding brokerage commissions. The other Shares were acquired by Mr. Eberwein as described above.

    In addition to the Shares, Mr. Eberwein owns 1,275,486 shares of the Issuer’s 10% Series A Cumulative Perpetual Preferred Stock.

    Item 5.Interest in Securities of the Issuer.

    Items 5(a)-(c) are hereby amended and restated to read as follows:

    The aggregate percentage of Shares reported owned by the Reporting Person is based upon 15,082,155 Shares outstanding, which is the total number of Shares outstanding based on information provided by the Issuer to the Reporting Person.

    A.Mr. Eberwein
    (a)As of the close of business on June 22, 2022, Mr. Eberwein beneficially owned 3,550,054 Shares (including 1,075,000 Shares underlying the Warrants, which are immediately exercisable).

    Percentage: Approximately 21.97%

    (b)1. Sole power to vote or direct vote: 3,550,054
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 3,550,054
    4. Shared power to dispose or direct the disposition: 0

     

    (c)The transactions in the Shares by the Reporting Person since the filing of Amendment No. 2 the Schedule 13D are set forth in Schedule A and are incorporated herein by reference.
    3

    CUSIP No. 85513Q103

    Item 6.Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

    Item 6 is hereby amended to add the following:

    On June 17, 2022, Mr. Eberwein entered into a new Rule 10b5-1 Buy Trading Plan (the “2022 Trading Plan”) with Clear Street LLC (“Broker”) for the purpose of establishing a trading plan to effect purchases of Shares of the Issuer in compliance with all applicable laws, including, without limitation, Section 10(b) of the Exchange Act and the rules and regulations promulgated thereunder, including, but not limited to, Rule 10b5-1. Broker is authorized to begin purchasing Shares pursuant to the 2022 Trading Plan on July 18, 2022. The 2022 Trading Plan expires on July 18, 2023, unless terminated earlier under certain conditions. A copy of the 2022 Trading Plan is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

    Item 7.Material to be Filed as Exhibits.

    Item 7 is hereby amended to add the following exhibit:

    99.1Rule 10b5-1 Buy Trading Plan, dated June 17, 2022, by and between Jeffrey E. Eberwein and Clear Street LLC.

     

    4

    CUSIP No. 85513Q103

     

    SIGNATURES

     

    After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

    Dated: June 22, 2022

     

     

    /s/ Jeffrey E. Eberwein

      JEFFREY E. EBERWEIN

     

    5

    CUSIP No. 85513Q103

    SCHEDULE A

    Transactions in the Shares Since the Filing of Amendment No. 2 to the Schedule 13D

    Shares of Common Stock

    Purchased/(Sold)

    Price Per

    Share ($)1

    Date of

    Purchase/Sale

         
    26,605 $1.062 06/03/2022
    22,393 $1.063 06/06/2022
    52,309 $1.064 06/07/2022
    8,764 $1.065 06/08/2022
    19,025 $1.066 06/09/2022
    113,010 $0.907 06/21/2022
    16,447 $0.92 06/22/2022 

    _______________

    1 The prices reported in this column are weighted average prices. Mr. Eberwein undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased (or sold) at each separate price such shares were purchased.

    2 These shares were purchased in multiple transactions at prices ranging from $1.06 to $1.06, inclusive.

    3 These shares were purchased in multiple transactions at prices ranging from $1.06 to $1.06, inclusive.

    4 These shares were purchased in multiple transactions at prices ranging from $1.05 to $1.06, inclusive.

    5 These shares were purchased in multiple transactions at prices ranging from $1.06 to $1.06, inclusive.

    6 These shares were purchased in multiple transactions at prices ranging from $1.06 to $1.06, inclusive.

    7 These shares were purchased in multiple transactions at prices ranging from $0.86 to $0.92, inclusive.

     

    Get the next $STRR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $STRR

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $STRR
    Financials

    Live finance-specific insights

    See more
    • Star Equity Holdings and Hudson Global Sign Definitive Merger Agreement

      Accretive Combination Increases Scale, Diversifies Revenue Streams, and Leverages Corporate Overhead and Public Company Costs Better Positions both Companies to Accelerate Growth and Maximize Shareholder Value Companies to Host a Joint Conference Call on May 22 at 10:00 am ET to Discuss the Merger OLD GREENWICH, Conn., May 21, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. ("Star") (NASDAQ:STRR, STRRP)) and Hudson Global, Inc. ("Hudson") (NASDAQ:HSON) (the "Companies"), announced today the signing of a definitive merger agreement (the "Merger"). Pursuant to the Merger, Star will merge with and into a wholly owned subsidiary of Hudson to form "NewCo". Prior to signing this Merger a

      5/21/25 4:45:03 PM ET
      $HSON
      $STRR
      Professional Services
      Consumer Discretionary
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings, Inc. Declares Cash Dividend of $0.25 Per Share of 10% Series A Cumulative Perpetual Preferred Stock

      OLD GREENWICH, Conn., May 20, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP)) ("Star" or the "Company"), a diversified holding company, announced today that its Board of Directors declared a cash dividend to holders of the Company's 10% Series A Cumulative Perpetual Preferred Stock of $0.25 per share. The record date for this dividend is June 1, 2025, and the payment date is June 10, 2025. About Star Equity Holdings, Inc.Star Equity Holdings, Inc. is a diversified holding company currently composed of three business divisions: Building Solutions, Energy Services, and Investments. Building SolutionsOur Building Solutions division operates in three businesses: (i)

      5/20/25 8:30:43 AM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings, Inc. Announces 2025 First Quarter Financial Results

      Q1 2025 revenues increased to $12.9 million vs. $9.1 million in Q1 2024 Alliance Drilling Tools acquisition marks entry into Energy Services Quarter-end Building Solutions backlog stands at record $27.9 million OLD GREENWICH, Conn., May 14, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP)) ("Star" or the "Company"), a diversified holding company, reported today its financial results for the first quarter (Q1) ended March 31, 2025. All 2025 and 2024 amounts in this release are unaudited. Q1 2025 Financial Highlights vs. Q1 2024 (unaudited) Revenues increased by 41.7% to $12.9 million from $9.1 million.Gross profi

      5/14/25 8:30:04 AM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $STRR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Star Equity Holdings and Hudson Global Sign Definitive Merger Agreement

      Accretive Combination Increases Scale, Diversifies Revenue Streams, and Leverages Corporate Overhead and Public Company Costs Better Positions both Companies to Accelerate Growth and Maximize Shareholder Value Companies to Host a Joint Conference Call on May 22 at 10:00 am ET to Discuss the Merger OLD GREENWICH, Conn., May 21, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. ("Star") (NASDAQ:STRR, STRRP)) and Hudson Global, Inc. ("Hudson") (NASDAQ:HSON) (the "Companies"), announced today the signing of a definitive merger agreement (the "Merger"). Pursuant to the Merger, Star will merge with and into a wholly owned subsidiary of Hudson to form "NewCo". Prior to signing this Merger a

      5/21/25 4:45:03 PM ET
      $HSON
      $STRR
      Professional Services
      Consumer Discretionary
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings, Inc. Declares Cash Dividend of $0.25 Per Share of 10% Series A Cumulative Perpetual Preferred Stock

      OLD GREENWICH, Conn., May 20, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP)) ("Star" or the "Company"), a diversified holding company, announced today that its Board of Directors declared a cash dividend to holders of the Company's 10% Series A Cumulative Perpetual Preferred Stock of $0.25 per share. The record date for this dividend is June 1, 2025, and the payment date is June 10, 2025. About Star Equity Holdings, Inc.Star Equity Holdings, Inc. is a diversified holding company currently composed of three business divisions: Building Solutions, Energy Services, and Investments. Building SolutionsOur Building Solutions division operates in three businesses: (i)

      5/20/25 8:30:43 AM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings, Inc. Announces 2025 First Quarter Financial Results

      Q1 2025 revenues increased to $12.9 million vs. $9.1 million in Q1 2024 Alliance Drilling Tools acquisition marks entry into Energy Services Quarter-end Building Solutions backlog stands at record $27.9 million OLD GREENWICH, Conn., May 14, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP)) ("Star" or the "Company"), a diversified holding company, reported today its financial results for the first quarter (Q1) ended March 31, 2025. All 2025 and 2024 amounts in this release are unaudited. Q1 2025 Financial Highlights vs. Q1 2024 (unaudited) Revenues increased by 41.7% to $12.9 million from $9.1 million.Gross profi

      5/14/25 8:30:04 AM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $STRR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Star Equity Holdings Inc.

      SC 13D/A - STAR EQUITY HOLDINGS, INC. (0000707388) (Subject)

      9/10/24 4:04:39 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13D/A filed by Star Equity Holdings Inc. (Amendment)

      SC 13D/A - STAR EQUITY HOLDINGS, INC. (0000707388) (Subject)

      9/18/23 4:05:02 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13D/A filed by Star Equity Holdings Inc. (Amendment)

      SC 13D/A - STAR EQUITY HOLDINGS, INC. (0000707388) (Subject)

      8/31/23 5:18:25 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $STRR
    Leadership Updates

    Live Leadership Updates

    See more
    • Star Equity Holdings, Inc. Appoints Rick Coleman as CEO

      OLD GREENWICH, Conn., April 01, 2022 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP))) ("Star Equity" or the "Company"), a diversified holding company, announced today the appointment of Richard ("Rick") K. Coleman, Jr. as Chief Executive Officer, effective April 1, 2022. In addition, Mr. Coleman will be nominated to serve as a director at the Company's upcoming annual meeting of shareholders. Mr. Coleman is a seasoned executive who brings to Star Equity extensive CEO leadership and board-level experience with numerous public and private companies. He was appointed as Star Equity's Chief Operating Officer in January 2022 and has provided valuable insights and direction

      4/1/22 8:00:00 AM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings, Inc. Adds Richard Coleman as Chief Operating Officer

      OLD GREENWICH, Conn., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP))) ("Star Equity" or the "Company"), a diversified holding company, announced today the appointment of Richard K. Coleman, Jr. ("Rick") as Chief Operating Officer, effective January 1, 2022. Coleman's addition increases the capacity of Star Equity's senior leadership team. In this role, he will oversee the Company's operations, assist its business leaders in achieving their growth and profitability goals, launch new business initiatives, as well as help analyze and integrate future acquisitions. Coleman brings more than 30 years of executive leadership experience with extensive expertis

      12/20/21 8:00:00 AM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings, Inc. Appoints John Gildea to its Board of Directors

      OLD GREENWICH, Conn., Aug. 06, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP))) ("Star Equity" or the "Company"), a diversified, multi-industry holding company with three business divisions, Healthcare, Construction, and Investments, announced today the appointment of John W. Gildea to its Board of Directors, effective immediately. Mr. Gildea's appointment as independent director expands Star Equity's Board to six members. Mr. Gildea will also serve on the Audit Committee. Mr. Gildea brings over three decades of experience investing in special situation debt and equity of small to middle market companies. He is the founding partner of Gildea Management Co., a fir

      8/6/21 4:38:13 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $STRR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Coleman Richard Kenneth Jr. bought $10,675 worth of shares (2,500 units at $4.27) and bought $4,925 worth of 10% Series A Cumulative Perpetual Preferred Stock (500 units at $9.85), decreasing direct ownership by 93% to 2,500 units (SEC Form 4)

      4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

      8/20/24 4:10:35 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Butcher Thatcher bought $3,120 worth of shares (3,000 units at $1.04), increasing direct ownership by 100% to 6,000 units (SEC Form 4)

      4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

      12/15/23 1:41:36 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Coleman Richard Kenneth Jr. bought $2,220 worth of shares (2,000 units at $1.11) and bought $18,900 worth of 10% Series A Cumulative Perpetual Preferred Stock (2,000 units at $9.45), decreasing direct ownership by 98% to 2,000 units (SEC Form 4)

      4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

      12/4/23 8:25:38 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $STRR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Parks Louis A.

      4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

      5/21/25 4:14:38 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 4 filed by Executive Chairman Eberwein Jeffrey E.

      4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

      5/21/25 4:13:02 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 4 filed by Director Palmer Jennifer

      4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

      5/21/25 4:11:19 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $STRR
    SEC Filings

    See more
    • SEC Form 425 filed by Star Equity Holdings Inc.

      425 - STAR EQUITY HOLDINGS, INC. (0000707388) (Subject)

      5/21/25 9:44:38 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure

      8-K - STAR EQUITY HOLDINGS, INC. (0000707388) (Filer)

      5/21/25 9:40:28 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - STAR EQUITY HOLDINGS, INC. (0000707388) (Filer)

      5/20/25 4:09:26 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care